Walleye Trading’s Syndax Pharmaceuticals SNDX Stock Holding History

Walleye Trading’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,300	Closed	-$287K	–	4425
2026 Q1	$287K	Sell	12,300 -1,400	-10%	-$30.4K	﹤0.01%	2905
2025 Q4	$288K	Buy	13,700 +2,200	+19%	+$38.4K	﹤0.01%	3187
2025 Q3	$177K	Hold	11,500	–	–	﹤0.01%	3426
2025 Q2	$108K	Buy	+11,500	New	+$127K	﹤0.01%	3559
2022 Q1	–	Sell	-3,100	Closed	-$68K	–	5880
2021 Q4	$68K	Sell	3,100 -4,600	-60%	-$85K	﹤0.01%	4548
2021 Q3	$147K	Buy	+7,700	New	+$128K	﹤0.01%	4132

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Walleye Trading's SNDX Position: Q2 2026 in Review

Walleye Trading sold out of Syndax Pharmaceuticals (SNDX) in Q2 2026, closing a stake of 416 shares — an estimated $9.72K sold.

Walleye Trading first reported a position in SNDX in Q1 2019 and held it in 8 quarters. The position peaked at $2.44M in Q4 2021. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

Walleye Trading reported no remaining Syndax Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Walleye Trading sold 416 Syndax Pharmaceuticals shares in Q2 2026, an estimated $9.72K.
Walleye Trading first reported a position in Syndax Pharmaceuticals in Q1 2019 and held it in 8 quarters.
Walleye Trading's Syndax Pharmaceuticals position peaked at $2.44M in Q4 2021.
242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.